CPC
GMAB icon

Cookson Peirce & Co’s Genmab GMAB Stock Holding History

Cookson Peirce & Co’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,940
Closed -$323K – 190
2020
Q4 		$323K Sell
7,940
-27,919
-78% -$1.04M 0.02% 133
2020
Q3 		$1.31M Buy
35,859
+9,039
+34% +$327K 0.1% 82
2020
Q2 		$909K Sell
26,820
-8,363
-24% -$228K 0.09% 80
2020
Q1 		$746K Buy
35,183
+3,418
+11% +$76.2K 0.09% 78
2019
Q4 		$709K Buy
+31,765
New +$693K 0.06% 104

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Cookson Peirce & Co's GMAB Position: Q1 2021 in Review

Cookson Peirce & Co sold out of Genmab (GMAB) in Q1 2021, closing a stake of 7,940 shares — an estimated $323K sold.

Cookson Peirce & Co first reported a position in GMAB in Q4 2019 and held it in 5 quarters. The position peaked at $1.31M in Q3 2020. 209 funds tracked by Wall St. Rank hold GMAB as of Q1 2021.

  • Cookson Peirce & Co reported no remaining Genmab position as of Q1 2021 after selling out during the quarter.
  • Cookson Peirce & Co sold 7,940 Genmab shares in Q1 2021, an estimated $323K.
  • Cookson Peirce & Co first reported a position in Genmab in Q4 2019 and held it in 5 quarters.
  • Cookson Peirce & Co's Genmab position peaked at $1.31M in Q3 2020.
  • 209 funds tracked by Wall St. Rank held Genmab as of Q1 2021.

Based on Cookson Peirce & Co's 13F filing for Q1 2021, filed 11 May 2021.